| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6246264 | Transplantation Proceedings | 2014 | 7 Pages |
Abstract
These results suggest that transitioning from aprotinin to EACA did not result in worse outcomes. In addition to decreased intraoperative blood loss, a trend toward improved graft and patient survival was seen in patients receiving EACA.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
R.S. Mangus, S.B. Kinsella, J.A. Fridell, C.A. Kubal, P. Lahsaei, L.O. Mark, A.J. Tector,